Novo Nordisk has accused rival Eli Lilly of runnin | Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public about the comparative efficacy of GLP-1 medicines.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads
Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs
Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses
GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign
Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads
Novo Nordisk suing Eli Lilly over GLP-1 ‘outdated’ advertisements - UPI.com
Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads
Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising
Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug
Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective…
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly…
Novo Nordisk sues Eli Lilly, alleging its Zepbound ads misleadingly compare doses against outdated Wegovy data.
"Through this action, Novo Nordisk is seeking a permanent injunction requiring Lilly to pull its misleading comparative…
The weight-loss drug wars reached a new level of intensity Tuesday as Novo Nordisk sued Eli Lilly, accusing its arch-rival of…
Novo Nordisk, the maker of Wegovy, has filed a lawsuit on Tuesday against competitor Eli Lilly alleging that its GLP-1…
